{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T09:59:12Z","timestamp":1772186352071,"version":"3.50.1"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.brainres.2007.09.006","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T10:34:59Z","timestamp":1190111699000},"page":"283-292","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Motor deficits and altered striatal gene expression in aphakia (ak) mice"],"prefix":"10.1016","volume":"1185","author":[{"given":"Bhupinder","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean H.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hema H.","family":"Vasavada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenchao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather G.","family":"Allore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline J.","family":"Zeiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2007.09.006_bib1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0928-0987(00)00170-6","article-title":"Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse","volume":"12","author":"Araki","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.brainres.2007.09.006_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/jnen\/63.1.20","article-title":"Intralaminar thalamic nuclei lesions: widespread impact on dopamine denervation-mediated cellular defects in the rat basal ganglia","volume":"63","author":"Bacci","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.brainres.2007.09.006_bib3","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/jnr.21164","article-title":"Alterations in prodynorphin, proenkephalin, and GAD67\u00a0mRNA levels in the aged human putamen: correlation with Parkinson's disease","volume":"85","author":"Backman","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2007.09.006_bib4","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.3920-03.2004","article-title":"Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor","volume":"24","author":"Baquet","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2007.09.006_bib5","first-page":"802","article-title":"The pathogenesis of Parkinson's disease: a new hypothesis","volume":"87","author":"Barbeau","year":"1962","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.brainres.2007.09.006_bib6","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1111\/j.1471-4159.1990.tb04922.x","article-title":"D1 and D2 dopaminergic regulation of acetylcholine release from striata of freely moving rats","volume":"54","author":"Bertorelli","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2007.09.006_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.expneurol.2004.05.041","article-title":"Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP","volume":"189","author":"Betarbet","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2007.09.006_bib8","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1523\/JNEUROSCI.21-17-06853.2001","article-title":"Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease","volume":"21","author":"Bezard","year":"2001","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.brainres.2007.09.006_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1124\/mol.107.035998","article-title":"Nigrostriatal damage preferentially decreases a subpopulation of alpha6beta2\u204e nAChRs in mouse, monkey, and Parkinson's disease striatum","volume":"72","author":"Bordia","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2007.09.006_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0166-2236(96)81862-5","article-title":"The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia","volume":"19","author":"Calabresi","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainres.2007.09.006_bib11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0166-2236(99)01501-5","article-title":"Acetylcholine-mediated modulation of striatal function","volume":"23","author":"Calabresi","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainres.2007.09.006_bib10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S1474-4422(06)70600-7","article-title":"A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine\u2013acetylcholine synaptic balance","volume":"5","author":"Calabresi","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2007.09.006_bib13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1353-8020(02)00029-9","article-title":"Levodopa response motor complications\u2014GABA receptors and preproenkephalin expression in human brain","volume":"8","author":"Calon","year":"2002","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2007.09.006_bib14","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/1531-8257(199911)14:6<972::AID-MDS1010>3.0.CO;2-0","article-title":"Oxidative DNA damage in the aging mouse brain","volume":"14","author":"Cardozo-Pelaez","year":"1999","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.brainres.2007.09.006_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0042-6989(01)00146-8","article-title":"Retinal degeneration mutants in the mouse","volume":"42","author":"Chang","year":"2002","journal-title":"Vision Res."},{"key":"10.1016\/j.brainres.2007.09.006_bib16","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ana.10577","article-title":"Weight loss in Parkinson's disease","volume":"53","author":"Chen","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2007.09.006_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.mcn.2004.09.008","article-title":"The homeodomain transcription factor Pitx3 facilitates differentiation of mouse embryonic stem cells into AHD2-expressing dopaminergic neurons","volume":"28","author":"Chung","year":"2005","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.brainres.2007.09.006_bib18","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.pbb.2005.07.005","article-title":"Scheduled access to ethanol results in motor impairment and tolerance in female C57BL\/6J mice","volume":"81","author":"Cronise","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2007.09.006_bib19","first-page":"775","article-title":"Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes","volume":"277","author":"DeBoer","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2007.09.006_bib20","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.2174\/092986706778521805","article-title":"Serotonin involvement in the basal ganglia pathophysiology: could the 5-HT2C receptor be a new target for therapeutic strategies?","volume":"13","author":"Di Giovanni","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.brainres.2007.09.006_bib21","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0306-4522(02)00778-9","article-title":"Motor behaviour deficits and their histopathological and functional correlates in the nigrostriatal system of dopamine transporter knockout mice","volume":"116","author":"Fernagut","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2007.09.006_bib22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.neurobiolaging.2004.04.005","article-title":"Effects of age and dopamine D2L receptor-deficiency on motor and learning functions","volume":"26","author":"Fetsko","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2007.09.006_bib23","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","article-title":"Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein","volume":"24","author":"Fleming","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2007.09.006_bib24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0736-5748(02)00009-6","article-title":"Motor and associative deficits in D2 dopamine receptor knockout mice","volume":"20","author":"Fowler","year":"2002","journal-title":"Int. J. Dev. Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.brainres.2007.09.006_bib25","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.parkreldis.2004.11.005","article-title":"Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors","volume":"11","author":"Guigoni","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6833","key":"10.1016\/j.brainres.2007.09.006_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35075076","article-title":"BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization","volume":"411","author":"Guillin","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2007.09.006_bib27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1006\/exnr.2000.7588","article-title":"Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility","volume":"168","author":"Hofele","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2007.09.006_bib28","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.pharmthera.2005.12.001","article-title":"What has been learnt from study of dopamine receptors in Parkinson's disease?","volume":"111","author":"Hurley","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainres.2007.09.006_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0169-328X(03)00162-1","article-title":"Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice","volume":"114","author":"Hwang","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.brainres.2007.09.006_bib30","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1523\/JNEUROSCI.3718-04.2005","article-title":"3,4-Dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease","volume":"25","author":"Hwang","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2007.09.006_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2005.02.023","article-title":"Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice","volume":"162","author":"Iancu","year":"2005","journal-title":"Behav. Brain Res."},{"issue":"Suppl 2","key":"10.1016\/j.brainres.2007.09.006_bib33","first-page":"II43","article-title":"Pathophysiology and biochemistry of dyskinesia: clues for the development of non-dopaminergic treatments","volume":"247","author":"Jenner","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.brainres.2007.09.006_bib34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0028-3908(94)00144-H","article-title":"Dopaminergic modulation of striatal acetylcholine release in rats depleted of dopamine as neonates","volume":"34","author":"Johnson","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2007.09.006_bib35","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0006-8993(93)90414-I","article-title":"Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. III. Results in Parkinson's disease cases","volume":"600","author":"Joyce","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2007.09.006_bib36","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.expneurol.2004.01.012","article-title":"Loss of D3 receptors in the zitter mutant rat is not reversed by l-dopa treatment","volume":"187","author":"Joyce","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2007.09.006_bib37","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.neurobiolaging.2006.02.010","article-title":"Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson's disease","volume":"28","author":"Kashani","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2007.09.006_bib38","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1046\/j.1460-9568.1999.00788.x","article-title":"Cortical and nigral deafferentation and striatal cholinergic markers in the rat dorsal striatum: different effects on the expression of mRNAs encoding choline acetyltransferase and muscarinic m1 and m4 receptors","volume":"11","author":"Kayadjanian","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2007.09.006_bib39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/mds.10042","article-title":"Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP","volume":"17","author":"Kim","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2007.09.006_bib40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/mol.61.1.230","article-title":"Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites","volume":"61","author":"Kulak","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2007.09.006_bib41","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1097\/00001756-200011270-00019","article-title":"Reduced reward processing in the brains of parkinsonian patients","volume":"11","author":"Kunig","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.brainres.2007.09.006_bib42","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0306-4522(83)90102-1","article-title":"The striatal cholinergic interneuron: synaptic target of dopaminergic terminals?","volume":"10","author":"Lehmann","year":"1983","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.brainres.2007.09.006_bib43","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ydbio.2007.04.034","article-title":"Sequential expression and redundancy of Pitx2 and Pitx3 genes during muscle development","volume":"307","author":"L'Honore","year":"2007","journal-title":"Dev. Biol."},{"key":"10.1016\/j.brainres.2007.09.006_bib44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archneur.64.1.137","article-title":"Pathophysiology of motor complications in Parkinson's disease: postsynaptic mechanisms are crucial","volume":"64","author":"Linazasoro","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainres.2007.09.006_bib45","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0304-3940(90)90463-J","article-title":"Bilateral regulation of glutamate tissue and extracellular levels in caudate\u2013putamen by midbrain dopamine neurons","volume":"115","author":"Lindefors","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2007.09.006_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0014-2999(89)90631-6","article-title":"Dopaminergic inhibition of striatal acetylcholine release after 6-hydroxydopamine","volume":"168","author":"MacKenzie","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2007.09.006_bib48","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/cs0830199","article-title":"Raised resting energy expenditure in Parkinson's disease and its relationship to muscle rigidity","volume":"83","author":"Markus","year":"1992","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.brainres.2007.09.006_bib49","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0014-4886(03)00050-5","article-title":"Enkephalin, neurotensin, and substance P immunoreactivity neurones of the rat GP following 6-hydroxydopamine lesion of the substantia nigra","volume":"183","author":"Martorana","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2007.09.006_bib50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","article-title":"Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion","volume":"73","author":"Matsuura","year":"1997","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.brainres.2007.09.006_bib51","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1124\/mol.105.012773","article-title":"Decrease in alpha3\u204e\/alpha6\u204e nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage","volume":"68","author":"McCallum","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2007.09.006_bib52","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0006-3223(03)00530-4","article-title":"Prevalence, etiology, and treatment of depression in Parkinson's disease","volume":"54","author":"McDonald","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2007.09.006_bib53","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0969-9961(03)00011-1","article-title":"Compensatory regulation of striatal neuropeptide gene expression occurs before changes in metabolic activity of basal ganglia nuclei","volume":"13","author":"Meissner","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2007.09.006_bib54","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1046\/j.1460-9568.1998.00264.x","article-title":"Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies","volume":"10","author":"Morissette","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2007.09.006_bib55","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1471-4159.1999.0720682.x","article-title":"Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists","volume":"72","author":"Morissette","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2007.09.006_bib56","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archneur.58.2.259","article-title":"Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders","volume":"58","author":"Muller","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainres.2007.09.006_bib57","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1054\/jocn.2001.1071","article-title":"Olfactory function in parkinsonian syndromes","volume":"9","author":"Muller","year":"2002","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.brainres.2007.09.006_bib58","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0169-328X(95)00317-L","article-title":"Partial striatal dopamine depletion differentially affects striatal substance P and enkephalin messenger RNA expression","volume":"37","author":"Nisenbaum","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.brainres.2007.09.006_bib59","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.0230529100","article-title":"Pitx3 is required for development of substantia nigra dopaminergic neurons","volume":"100","author":"Nunes","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2007.09.006_bib60","first-page":"435","article-title":"A simple quantitative bradykinesia test in MPTP-treated mice","volume":"50","author":"Ogawa","year":"1985","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.brainres.2007.09.006_bib61","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1474-4422(06)70521-X","article-title":"Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications","volume":"5","author":"Olanow","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2007.09.006_bib62","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00002826-199208000-00008","article-title":"Exacerbation of parkinsonism by tacrine","volume":"15","author":"Ott","year":"1992","journal-title":"Clin. Neuropharmacol."},{"issue":"9","key":"10.1016\/j.brainres.2007.09.006_bib63","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","article-title":"Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR","volume":"30","author":"Pfaffl","year":"2002","journal-title":"Nucleic Acids Res."},{"issue":"Pt 8","key":"10.1016\/j.brainres.2007.09.006_bib64","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/brain\/122.8.1449","article-title":"Striatal dopaminergic markers in dementia with lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution","volume":"122","author":"Piggott","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2007.09.006_bib65","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0306-4522(00)00130-5","article-title":"Expression of D(3) receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: effect of levodopa treatment","volume":"98","author":"Quik","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2007.09.006_bib66","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0306-4522(02)00167-7","article-title":"Increases in striatal preproenkephalin gene expression are associated with nigrostriatal damage but not l-DOPA-induced dyskinesias in the squirrel monkey","volume":"113","author":"Quik","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2007.09.006_bib67","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1124\/mol.63.5.1169","article-title":"Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice","volume":"63","author":"Quik","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2007.09.006_bib68","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/mol.104.006015","article-title":"Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or l-DOPA","volume":"67","author":"Quik","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2007.09.006_bib69","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0304-3940(02)01423-4","article-title":"Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data","volume":"339","author":"Ramakers","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2007.09.006_bib70","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/geno.2000.6464","article-title":"A double-deletion mutation in the Pitx3 gene causes arrested lens development in aphakia mice","volume":"72","author":"Rieger","year":"2001","journal-title":"Genomics"},{"key":"10.1016\/j.brainres.2007.09.006_bib71","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1460-9568.2004.03591.x","article-title":"Chronic l-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease","volume":"20","author":"Robelet","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2007.09.006_bib72","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/mds.870130506","article-title":"Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease","volume":"13","author":"Ryoo","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2007.09.006_bib73","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/S0024-3205(01)01055-4","article-title":"Neostriatal muscarinic receptor subtypes involved in the generation of tremulous jaw movements in rodents implications for cholinergic involvement in parkinsonism","volume":"68","author":"Salamone","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2007.09.006_bib74","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00109-006-0097-6","article-title":"Quantitative real-time RT-PCR data analysis: current concepts and novel \u201cgene expression's Ct difference\u201d formula","volume":"84","author":"Schefe","year":"2006","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.brainres.2007.09.006_bib76","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1001958023096","article-title":"MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences","volume":"30","author":"Sedelis","year":"2000","journal-title":"Behav. Genet."},{"key":"10.1016\/j.brainres.2007.09.006_bib75","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson's disease","volume":"125","author":"Sedelis","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2007.09.006_bib78","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/hmg\/6.12.2109","article-title":"Isolation of a new homeobox gene belonging to the Pitx\/Rieg family: expression during lens development and mapping to the aphakia region on mouse chromosome 19","volume":"6","author":"Semina","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainres.2007.09.006_bib77","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/hmg\/9.11.1575","article-title":"Deletion in the promoter region and altered expression of Pitx3 homeobox gene in aphakia mice","volume":"9","author":"Semina","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainres.2007.09.006_bib79","doi-asserted-by":"crossref","first-page":"13305","DOI":"10.1073\/pnas.94.24.13305","article-title":"A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons","volume":"94","author":"Smidt","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2007.09.006_bib80","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1242\/dev.01022","article-title":"Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3","volume":"131","author":"Smidt","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.brainres.2007.09.006_bib81","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.mcn.2005.07.018","article-title":"Molecular and cellular alterations in the Pitx3-deficient midbrain dopaminergic system","volume":"30","author":"Smits","year":"2005","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.brainres.2007.09.006_bib82","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0896-6273(01)00319-1","article-title":"Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice","volume":"30","author":"Szczypka","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2007.09.006_bib83","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1001\/archneur.61.11.1705","article-title":"Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study","volume":"61","author":"Thobois","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainres.2007.09.006_bib84","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0163-1047(83)90876-2","article-title":"A behavior analysis of the offspring of \u201chaloperidol-sensitive\u201d and \u201chaloperidol-resistant\u201d gerbils","volume":"39","author":"Upchurch","year":"1983","journal-title":"Behav. Neural Biol."},{"key":"10.1016\/j.brainres.2007.09.006_bib85","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1242\/dev.00464","article-title":"Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons","volume":"130","author":"van den Munckhof","year":"2003","journal-title":"Development"},{"key":"10.1016\/j.brainres.2007.09.006_bib86","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1471-4159.2005.03522.x","article-title":"Striatal neuroadaptation and rescue of locomotor deficit by l-dopa in aphakia mice, a model of Parkinson's disease","volume":"96","author":"van den Munckhof","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2007.09.006_bib87","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0006-8993(01)02513-6","article-title":"Changes in striatal dopamine D3 receptor regulation during expression of and recovery from MPTP-induced parkinsonism","volume":"905","author":"Wade","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2007.09.006_bib88","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(00)00005-4","article-title":"Presynaptic nicotinic receptors modulating dopamine release in the rat striatum","volume":"393","author":"Wonnacott","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2007.09.006_bib90","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1073858402239588","article-title":"Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems","volume":"9","author":"Zhou","year":"2003","journal-title":"Neuroscientist"},{"key":"10.1016\/j.brainres.2007.09.006_bib91","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1523\/JNEUROSCI.22-20-08785.2002","article-title":"Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum","volume":"22","author":"Zoli","year":"2002","journal-title":"J. Neurosci."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899307021464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899307021464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,26]],"date-time":"2020-04-26T11:13:58Z","timestamp":1587899638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899307021464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":88,"alternative-id":["S0006899307021464"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2007.09.006","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}